Press/Media
- 1 - 25 out of 141 results
Search results
-
Weekly: Fate Therapeutics (FATE: $1.45) shares post best week in eleven weeks; +18c [14.2%]
2/15/25
1 item of Media coverage
Press/Media: Press / Media
-
-
Weekly: Fate Therapeutics (FATE: $1.27) shares post worst week in three weeks; -3c [2.3%]
2/8/25
1 item of Media coverage
Press/Media: Press / Media
-
Fate Therapeutics crashes 79% in past year, underperforming 92% of the market
2/4/25
1 item of Media coverage
Press/Media: Press / Media
-
Fate Therapeutics tumbles 21% in 2025, underperforming 92% of its global peers
2/4/25
1 item of Media coverage
Press/Media: Press / Media
-
Monthly: Fate Therapeutics (FATE: $1.30) falls for a fourth consecutive month, a four-month fall of 63%
2/3/25
1 item of Media coverage
Press/Media: Press / Media
-
Weekly: Fate Therapeutics (FATE: $1.33) climbs 4.7% on weak volume; +6c [4.7%]
1/25/25
1 item of Media coverage
Press/Media: Press / Media
-
Weekly: Fate Therapeutics (FATE: $1.27) plunges 13% - trailing 95% of stocks; -19.5c [13.3%]
1/18/25
1 item of Media coverage
Press/Media: Press / Media
-
Weekly: Fate Therapeutics (FATE: $1.46) plummets 18% - trailing 90% of stocks; -33c [18.4%]
1/11/25
1 item of Media coverage
Press/Media: Press / Media
-
-
Fate Therapeutics plummets 55% in past year, underperforming 82% of the market
1/6/25
1 item of Media coverage
Press/Media: Press / Media
-
Fate Therapeutics plummets 56% in 2024, underperforming 83% of the market
1/6/25
1 item of Media coverage
Press/Media: Press / Media
-
Weekly: Fate Therapeutics (FATE: $1.80) shares post best week in five weeks; +19c [11.8%]
1/4/25
1 item of Media coverage
Press/Media: Press / Media
-
Monthly: Fate Therapeutics (FATE: $1.65) drops 38% on high volatility in December 2024
1/2/25
1 item of Media coverage
Press/Media: Press / Media
-
Weekly: Fate Therapeutics (FATE: $1.61) falls 4.2% on thin volume; -7c [4.2%]
12/28/24
1 item of Media coverage
Press/Media: Press / Media
-
Weekly: Fate Therapeutics (FATE: $1.68) sinks 8% - trailing 89% of stocks; -15c [8.2%] Vol Index 1.7 [1 is avg]
12/21/24
1 item of Media coverage
Press/Media: Press / Media
-
Fate Therapeutics plummets 49% in 2024, underperforming 87% of its global peers
12/13/24
1 item of Media coverage
Press/Media: Press / Media
-
Weekly: Fate Therapeutics (FATE: $2.29) shares post best week in ten weeks; +27c [13.4%] Vol Index 2.7 [1 is avg]
11/23/24
1 item of Media coverage
Press/Media: Press / Media
-
Weekly: Fate Therapeutics (FATE: $2.02) shares post worst week in three weeks; -40c [16.5%]
11/16/24
1 item of Media coverage
Press/Media: Press / Media
-
Weekly: Fate Therapeutics (FATE: $2.40) in bottom 1% performers of NASDAQ market in past week; -3c [1.2%]
11/9/24
1 item of Media coverage
Press/Media: Press / Media
-
-
-
Fate Therapeutics tumbles 37% in 2024, underperforming 85% of its global peers
11/4/24
1 item of Media coverage
Press/Media: Press / Media
-
Weekly: Fate Therapeutics (FATE: $2.42) sinks 9% - trailing 83% of stocks; -23c [8.7%]
11/2/24
1 item of Media coverage
Press/Media: Press / Media
-
Monthly: Fate Therapeutics (FATE: $2.37) shares post worst month in six months
11/1/24
1 item of Media coverage
Press/Media: Press / Media